Content about Matrix Labs

October 19, 2011
Mylan's Matrix Labs subsidiary gets name change

Mylan's India-based subsidiary is changing its name, Mylan said Wednesday.

September 20, 2011
Under PEPFAR, Matrix granted tentative approval for novel co-packaged HIV/AIDS treatment

Mylan subsidiary Matrix Labs has received tentative approval from the Food and Drug Administration for its new drug application of a co-packaged antiretroviral treatment under the President's Emergency Plan for AIDS Relief.

July 19, 2011
Matrix expands licensing agreement with Gilead for HIV/AIDS therapies

Mylan subsidiary Matrix Labs has expanded its licensing agreement with Gilead Sciences.

June 7, 2011
Mylan subsidiary gets OK for generic Aricept

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

May 31, 2011
Mylan to re-brand Matrix subsidiary

Generic drug maker Mylan plans to give one of its subsidiaries a new name, the company said.

March 10, 2011
Under PEPFAR, Matrix Labs gets OK to sell zidovudine tablets

A subsidiary of Mylan has won approval to sell a generic drug for HIV and AIDS in developing countries under the President’s Emergency Plan for AIDS Relief.

February 28, 2011
Matrix Labs' gabapentin capsules get FDA OK

The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

January 27, 2011
Matrix obtains license agreement for HIV treatment

A Mylan subsidiary has inked a nonexclusive license agreement with Tibotec Pharmaceuticals to manufacture, market and distribute a generic version of an HIV treatment.

January 24, 2011
Matrix Labs' generic Protonix DR receives FDA approval

The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday.

January 20, 2011
Under PEPFAR, Matrix gets tentative approval for generic Combivir

The Food and Drug Administration has given tentative approval to an antiretroviral treatment for children with HIV and AIDS under the President’s Emergency Plan for AIDS Relief program.

December 7, 2010
Under PEPFAR, Matrix gets tentative approval for Ziagen generic

The Food and Drug Administration has given tentative approval to a generic drug for HIV/AIDS made by Mylan subsidiary Matrix Labs for distribution in developing countries under the President’s Emergency Plan for AIDS Relief, Mylan said Tuesday.

October 4, 2010
Mylan subsidiary gets approval for HIV generic under PEPFAR

The Food and Drug Administration has approved a generic drug for HIV made by a...

© 2013 Drug Store News. All Rights Reserved.